Device Trial Radar · NCT01919385
Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia
Last checked: Nov 19, 2026Latest source record: Sep 19, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Planned (sponsor's estimate)
Start
Jul 2013
Primary completion
Sep 2013
Study completion Sep 2013
Sponsor
- Lead sponsor
- Animas CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 9, 2013
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- Who can join
- All sexes, from 21 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will be conducted in a Clinical Research Center (CRC) setting and recruiting type 1 diabetes that are currently using an insulin pump.
Conditions
- Type 1 Diabetes
Interventions
Predictive Low Glucose MinimizerDevice
This study is a non-randomized feasibility study enrolling type 1 diabetics who are currently using an insulin pump. Participating Investigators will closely monitor the study subject in a clinical research center environment for approximately 30 hours, while controller algorithm determined insulin doses are delivered by an insulin pump, and utilizing continuous glucose monitoring results.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate the performance of the System while the subject is under close medical supervision in the Clinical Research Center (CRC) settingTime frame: 1 week after subject is enrolled in the study
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Samsum Diabetes Reserach Inst.
Santa Barbara, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.